Skip to main content
Erschienen in: Journal of Diabetes & Metabolic Disorders 1/2020

02.04.2020 | Research article

A Bayesian analysis for investigating the association between rs13266634 polymorphism in SLC30A8 gene and type 2 diabetes

verfasst von: Ali Reza Soltanian, Bistoon Hosseini, Hossein Mahjub, Fatemeh Bahreini, Mohammad Ebrahim Ghaffari

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study was to evaluate the association between rs13266634 polymorphism in SLC30A8 gene and type 2 diabetes in Iranian population, and also to provide a way for adjusting the deviation from the Hardy-Weinberg equilibrium.

Methods

This was a case-control study, the patients were selected from the East Azerbaijan province, Iran. In this study, 125 patients with type 2 diabetes (cases) and 125 healthy individuals (controls) were studied. Genotype and allele frequencies were determined in both groups, and the deviations from the Hardy-Weinberg equilibrium were assessed using Bayesian analysis.

Results

A statistically significant association was observed between rs13266634 polymorphism in SLC30A8 gene and type 2 diabetes. In genotype assessing, data analysis showed that, TT genotype play a role in diabetes type 2 risk (P = 0.001). Subjects with TT genotype had a lower risk of diabetes compared to those with CC and CT genotypes. Also, there was no significant relationship between this polymorphism and type 2 diabetes mellitus in the absence of Hardy-Weinberg equilibrium.

Conclusion

Our findings show that, rs13266634 polymorphism was associated with the type 2 diabetes risk in the population of Eastern Azerbaijan province; however, the low number of TT homozygous genotypes affected the precision of the results. Also, the deviation from HWE affected the results. It is recommended to perform further studies to establish Hardy-Weinberg equilibrium. The inconsistency in the results may be due to the ignorance of this equilibrium.
Literatur
1.
Zurück zum Zitat Ding W, Xu L, Zhang L, Han Z, Jiang Q, Wang Z, et al. Meta-analysis of association between TCF7L2 polymorphism rs7903146 and type 2 diabetes mellitus. BMC Med Genet. 2018;19(1):38.CrossRef Ding W, Xu L, Zhang L, Han Z, Jiang Q, Wang Z, et al. Meta-analysis of association between TCF7L2 polymorphism rs7903146 and type 2 diabetes mellitus. BMC Med Genet. 2018;19(1):38.CrossRef
2.
Zurück zum Zitat Zhang Y, Pan X-F, Chen J, Xia L, Cao A, Zhang Y, et al. Combined lifestyle factors and risk of incident type 2 diabetes and prognosis among individuals with type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies. Diabetologia. 2020;63(1):21–33.PubMed Zhang Y, Pan X-F, Chen J, Xia L, Cao A, Zhang Y, et al. Combined lifestyle factors and risk of incident type 2 diabetes and prognosis among individuals with type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies. Diabetologia. 2020;63(1):21–33.PubMed
3.
Zurück zum Zitat James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858.CrossRef James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858.CrossRef
4.
Zurück zum Zitat Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389(10085):2239–51.CrossRef Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389(10085):2239–51.CrossRef
5.
Zurück zum Zitat Szabo M, Máté B, Csép K, Benedek T. Genetic approaches to the study of gene variants and their impact on the pathophysiology of type 2 diabetes. Biochem Genet. 2018;56(1–2):22–55.CrossRef Szabo M, Máté B, Csép K, Benedek T. Genetic approaches to the study of gene variants and their impact on the pathophysiology of type 2 diabetes. Biochem Genet. 2018;56(1–2):22–55.CrossRef
6.
Zurück zum Zitat Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010;42(7):579–89.CrossRef Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010;42(7):579–89.CrossRef
7.
Zurück zum Zitat Gruber K. Moving towards a more precise treatment of diabetes. Lancet Diabetes Endocrinol. 2015;3(3):171.CrossRef Gruber K. Moving towards a more precise treatment of diabetes. Lancet Diabetes Endocrinol. 2015;3(3):171.CrossRef
8.
Zurück zum Zitat Li M, Li C. Assessing departure from hardy-Weinberg equilibrium in the presence of disease association. GENET EPIDEMIOL. 2008;32(7):589–99.CrossRef Li M, Li C. Assessing departure from hardy-Weinberg equilibrium in the presence of disease association. GENET EPIDEMIOL. 2008;32(7):589–99.CrossRef
9.
Zurück zum Zitat Namipashaki A, Razaghi-Moghadam Z, Ansari-Pour N. The essentiality of reporting Hardy-Weinberg equilibrium calculations in population-based genetic association studies. Cell J. 2015;17(2):187.PubMedPubMedCentral Namipashaki A, Razaghi-Moghadam Z, Ansari-Pour N. The essentiality of reporting Hardy-Weinberg equilibrium calculations in population-based genetic association studies. Cell J. 2015;17(2):187.PubMedPubMedCentral
10.
Zurück zum Zitat Preuß Michael H, Ziegler A. Comments on: association study between coronary artery disease and rs1333049 and rs10757274 polymorphisms at 9p21 locus in south-West Iran. Cell J. 2016;17(4):756. Preuß Michael H, Ziegler A. Comments on: association study between coronary artery disease and rs1333049 and rs10757274 polymorphisms at 9p21 locus in south-West Iran. Cell J. 2016;17(4):756.
11.
Zurück zum Zitat Mohaddes S, Karami F, Gharesouran J, Bahrami A. The soluble carrier 30 A8 (SLC30A8) gene polymorphism and risk of diabetes mellitus type 2 in eastern Azerbijan population of Iran. J.Sci.I.R.I. 2012;23(1):15–20. Mohaddes S, Karami F, Gharesouran J, Bahrami A. The soluble carrier 30 A8 (SLC30A8) gene polymorphism and risk of diabetes mellitus type 2 in eastern Azerbijan population of Iran. J.Sci.I.R.I. 2012;23(1):15–20.
12.
Zurück zum Zitat Wakefield J. Bayesian methods for examining Hardy–Weinberg equilibrium. Biometrics. 2010;66(1):257–65.CrossRef Wakefield J. Bayesian methods for examining Hardy–Weinberg equilibrium. Biometrics. 2010;66(1):257–65.CrossRef
13.
Zurück zum Zitat Sandhu MS, Weedon MN, Fawcett KA, Wasson J, Debenham SL, Daly A, et al. Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet. 2007;39(8):951–3.CrossRef Sandhu MS, Weedon MN, Fawcett KA, Wasson J, Debenham SL, Daly A, et al. Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet. 2007;39(8):951–3.CrossRef
14.
Zurück zum Zitat Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007;316(5829):1331–6.CrossRef Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007;316(5829):1331–6.CrossRef
15.
Zurück zum Zitat Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445(7130):881–5.CrossRef Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445(7130):881–5.CrossRef
16.
Zurück zum Zitat Hu C, Zhang R, Wang C, Wang J, Ma X, Lu J, et al. PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a chinese population. PLoS One. 2009;4(10). Hu C, Zhang R, Wang C, Wang J, Ma X, Lu J, et al. PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a chinese population. PLoS One. 2009;4(10).
17.
Zurück zum Zitat Kommoju UJ, Samy SK, Maruda J, Irgam K, Kotla JP, Velaga L, et al. Association of CDKAL1, CDKN2A/B & HHEX gene polymorphisms with type 2 diabetes mellitus in the population of Hyderabad, India. Indian J Med Res. 2016;143(4):455–63.CrossRef Kommoju UJ, Samy SK, Maruda J, Irgam K, Kotla JP, Velaga L, et al. Association of CDKAL1, CDKN2A/B & HHEX gene polymorphisms with type 2 diabetes mellitus in the population of Hyderabad, India. Indian J Med Res. 2016;143(4):455–63.CrossRef
18.
Zurück zum Zitat Suzuki K, Akiyama M, Ishigaki K, Kanai M, Hosoe J, Shojima N, et al. Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population. Nat Genet. 2019;51(3):379–86.CrossRef Suzuki K, Akiyama M, Ishigaki K, Kanai M, Hosoe J, Shojima N, et al. Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population. Nat Genet. 2019;51(3):379–86.CrossRef
19.
Zurück zum Zitat Lee Y-H, Kang ES, Kim SH, Han SJ, Kim CH, Kim HJ, et al. Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population. J Hum Genet. 2008;53(11–12):991–8.CrossRef Lee Y-H, Kang ES, Kim SH, Han SJ, Kim CH, Kim HJ, et al. Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population. J Hum Genet. 2008;53(11–12):991–8.CrossRef
20.
Zurück zum Zitat Xu K, Zha M, Wu X, Yu Z, Yu R, Xu X, et al. Association between rs13266634 C/T polymorphisms of solute carrier family 30 member 8 (SLC30A8) and type 2 diabetes, impaired glucose tolerance, type 1 diabetes—a meta-analysis. Diabetes Res Clin Pract. 2011;91(2):195–202.CrossRef Xu K, Zha M, Wu X, Yu Z, Yu R, Xu X, et al. Association between rs13266634 C/T polymorphisms of solute carrier family 30 member 8 (SLC30A8) and type 2 diabetes, impaired glucose tolerance, type 1 diabetes—a meta-analysis. Diabetes Res Clin Pract. 2011;91(2):195–202.CrossRef
21.
Zurück zum Zitat Al-Rubeaan K, Siddiqui K, Saeb AT, Nazir N, Al-Naqeb D, Al-Qasim S. ACE I/D and MTHFR C677T polymorphisms are significantly associated with type 2 diabetes in Arab ethnicity: a meta-analysis. Gene. 2013;520(2):166–77.CrossRef Al-Rubeaan K, Siddiqui K, Saeb AT, Nazir N, Al-Naqeb D, Al-Qasim S. ACE I/D and MTHFR C677T polymorphisms are significantly associated with type 2 diabetes in Arab ethnicity: a meta-analysis. Gene. 2013;520(2):166–77.CrossRef
22.
Zurück zum Zitat Fan M, Li W, Wang L, Gu S, Dong S, Chen M, et al. Association of SLC30A8 gene polymorphism with type 2 diabetes, evidence from 46 studies: a meta-analysis: Springer; 2016. Fan M, Li W, Wang L, Gu S, Dong S, Chen M, et al. Association of SLC30A8 gene polymorphism with type 2 diabetes, evidence from 46 studies: a meta-analysis: Springer; 2016.
23.
Zurück zum Zitat Ng MC, Park KS, Oh B, Tam CH, Cho YM, Shin HD, et al. Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians. Diabetes. 2008;57(8):2226–33.CrossRef Ng MC, Park KS, Oh B, Tam CH, Cho YM, Shin HD, et al. Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians. Diabetes. 2008;57(8):2226–33.CrossRef
24.
Zurück zum Zitat Cho Y, Kim T, Lim S, Choi S, Shin H, Lee H, et al. Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. Diabetologia. 2009;52(2):253–61.CrossRef Cho Y, Kim T, Lim S, Choi S, Shin H, Lee H, et al. Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. Diabetologia. 2009;52(2):253–61.CrossRef
25.
Zurück zum Zitat Shokrzadeh M, Mohammad PA, Gerami M, Daryaei M, Abbasi RM, Rajabi SSM. Evaluation of SLC30A8 gene polymorphism (RS13266634) distribution in patients with diabetes type 2 in west Mazandaran-Iran. 2018. Shokrzadeh M, Mohammad PA, Gerami M, Daryaei M, Abbasi RM, Rajabi SSM. Evaluation of SLC30A8 gene polymorphism (RS13266634) distribution in patients with diabetes type 2 in west Mazandaran-Iran. 2018.
26.
Zurück zum Zitat Salem SD, Saif-Ali R, Ismail IS, Al-Hamodi Z, Muniandy S. Contribution of SLC30A8 variants to the risk of type 2 diabetes in a multi-ethnic population: a case control study. BMC Endocr Disord. 2014;14(1):2.CrossRef Salem SD, Saif-Ali R, Ismail IS, Al-Hamodi Z, Muniandy S. Contribution of SLC30A8 variants to the risk of type 2 diabetes in a multi-ethnic population: a case control study. BMC Endocr Disord. 2014;14(1):2.CrossRef
27.
Zurück zum Zitat Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, Von Elm E, et al. STrengthening the REporting of genetic association studies (STREGA): an extension of the STROBE statement. Hum Genet. 2009;125(2):131–51.CrossRef Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, Von Elm E, et al. STrengthening the REporting of genetic association studies (STREGA): an extension of the STROBE statement. Hum Genet. 2009;125(2):131–51.CrossRef
Metadaten
Titel
A Bayesian analysis for investigating the association between rs13266634 polymorphism in SLC30A8 gene and type 2 diabetes
verfasst von
Ali Reza Soltanian
Bistoon Hosseini
Hossein Mahjub
Fatemeh Bahreini
Mohammad Ebrahim Ghaffari
Publikationsdatum
02.04.2020
Verlag
Springer International Publishing
Erschienen in
Journal of Diabetes & Metabolic Disorders / Ausgabe 1/2020
Elektronische ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-020-00514-3

Weitere Artikel der Ausgabe 1/2020

Journal of Diabetes & Metabolic Disorders 1/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.